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1. Introduction
Protein and organelle turnover is essential to maintain cellular homeostasis and survival.
Removing and recycling cell constituents is achieved by autophagy in all cells, including
neurons. Autophagy contributes to various physiological processes, such as intracellular
cleansing, cellular homeostasis, development, differentiation, longevity, tumor suppression,
elimination of invading pathogens, antigen transport to the innate and adaptative immune
systems, and counteracting endoplasmic reticulum (ER) stress and diseases characterized by
the accumulation of protein aggregates [1]. Autophagy plays a role in a number of infectious
and inflammatory diseases, in addition to protein unfolding and misfolding diseases that lead
to neuron, muscle and liver degeneration or heart failure [2-4]. Whereas autophagy has long
been defined as a form of non-apoptotic, programmed cell death [5], recent findings suggest
that autophagy functions primarily to sustain cells, and only defects in autophagy lead to cell
death [6].
2. Autophagy in neuronal physiology
Autophagy was initially identified and characterized in a few cell types including neurons.
The distinct vacuoles which feature this self-eating process were originally described at the
ultrastructural level [7, 8]. The formation of autophagosomes was associated with chromatol‐
ysis of a restricted neuroplasm area, free of organelles, but filled with various types of vesicles
[9]. The function of autophagy in mature neurons , however, is still debated. In comparison
with other organs, rodent brains show high expression levels of autophagy-related (Atg)
proteins and low levels of autophagy markers such as autophagosome number and LC3-II.
Indeed, even under prolonged fasting conditions, the number of autophagosomes does not
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increase in neurons, probably because their nutrient supply from peripheral organs is main‐
tained [10]. However, mice with CNS defects in their autophagic machinery exhibit neuro‐
logical deficits, such as abnormal limb-clasping reflexes, locomotor ataxia, and lack of motor
coordination, in addition to a significant loss of large pyramidal neurons in the cerebral cortex
and Purkinje cells (PCs) in the cerebellar cortex [11-13].
Macroautophagy (hereafter referred to as autophagy) is initiated when a portion of the
cytoplasm is sequestrated within a double-membrane organelle, the so-called autophagosome
[14]. The autophagic machinery has been extensively detailed at the molecular level in a
number of reviews including several chapters of this book [14-17]. Atg and several non-Atg
proteins have been identified as regulators of key steps leading to the degradation of cytosolic
components in lysosomes: initiation and nucleation of phagophores, expansion of autopha‐
gosomes, maturation of autophagosomes into amphisomes/autolysosomes, and execution of
autophagic degradation [18]. The endosomal sorting complex required for transport (ESCRT)
pathway functions in the sorting of transmembrane proteins into the inner vesicles of multi‐
vesicular bodies (MVB) during endocytosis. Also it is conceivably an essential part of the basal
autophagy process in neurons because ubiquitin- or p62/SQSTM1 (p62)-labelled inclusions
and autophagosomes accumulate in neurons deficient in ESCRT components [19]. Increasing
evidence suggests that autophagy is regulated in a cell type-specific manner and as such
autophagy may serve a distinct function in neurons and may show difference in the molecular
machinery underlying basal autophagy (Fig. 1).
2.1. Axonal autophagy
In neurons, autophagy occurs in axons, suggesting that it may be uniquely regulated in this
compartment and specifically adapted to local axonal physiology [20]. In primary dorsal root
ganglion neurons, autophagosomes initiate distally in nerve terminals and mature during their
transport toward the cell soma [21, 22]. In non-neuronal cells, the autophagosomal membrane
has multiple possible origins, including endocytosed plasma membrane (amphisome), ER,
mitochondria, and trans-Golgi membranes [18, 21, 23- 32]. In contrast, the origin of autopha‐
gosomes in the axons is likely to be restricted to the sources of membrane available in the
terminals such as smooth ER and plasma membrane [33, 34], excluding rough ER and Golgi
dictyosomes.
As observed in ultrastructural studies of axotomized neurons [9, 35], analysis of Purkinje cell
(PC) degeneration in lurcher mutant GluRδ2Lc [36] demonstrates autophagosomes in their
axonal compartment. In this study, an excitotoxic insult mediated by GluRδ2Lc triggered a
rapid and robust accumulation of autophagosomes in dystrophic axonal swellings providing
evidence that autophagy is induced in dystrophic terminals and that autophagosome biogen‐
esis occurs in axons [37]. The molecular scenario underlying the initiation of this axonal
autophagy is unclear. Liang et al. [38] suggested that autophagy in lurcher PCs could be directly
activated by an interaction between the postsynaptic GluRδ2Lc, nPIST and beclin 1 an important
regulator of autophagy. Nevertheless, how activation of this postsynaptic signaling pathway
in dendrites initiates autophagosome formation in axon compartments is uncertain. PC death
that is correlated with early signs of autophagy appears to be independent of depolarization
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in the heteroallelic mutant Lurcher/hotfoot bearing only one copy of the lurcher allele and no
wild-type GRID2 [39]. However, in the lurcher mutant bearing only one copy of the lurcher
allele and one copy of the wild-type GRID2 allele, the leaky channel of GluRδ2Lc depolarizes
the neuron and this could transduce an electrical signal to the distal ends causing rapid
physiological changes within axons. This effect combined with the local changes in postsy‐
naptic signaling in dendrites may promote autophagosome biogenesis [37, 40].
2.2. Microtubule-dependent dynamics of neuronal autophagy
Previous data indicate that autophagy is a microtubule-dependent process. In cultured
sympathetic neurons, autophagosomes formed in the distal ends of axon undergo retrograde
transport along microtubules to the cell body where lysosomes that are necessary for the
degradation step of autophagy are usually located [21]. Consistent with these observations,
prominent retrograde transport of GFP-LC3-labelled autophagosomes has been observed in
the axons of primary cerebellar granule cells [36]. In serum-deprived PC12 cells, autolysosomes
formed by fusion of autophagosomes with lysosomes move in both anterograde and retro‐
Figure 1. Physiological neuronal autophagy. Autophagy recycles synaptic components to sustain neuronal homeo‐
stasis and regulate synaptic plasticity and growth. 1. Autophagic degradation of organelles, synaptic vesicles and pro‐
teins. 2. ULK1-mediated autophagy of endocytosed NGF-bound TrkA receptors. 3. Dynein-mediated retrograde
transport of autophagosomes. 4. GluRδ2 activation of beclin 1-dependent autophagy via nPIST. 5. Targeting of post‐
synaptic receptors to autophagosomes via endocytosis. 6. Kinesin-dependent anterograde transport of autophago‐
somes. 7. Formation of autophagolysosomes by fusion of autophagosomes with lysosomes.
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grade directions in neurites, and this trafficking requires microtubules [41]. Furthermore, both
pharmacological and siRNA-based inhibition of directional microtubule motor proteins
kinesin and dynein partially block respectively, anterograde and retrograde neuritic transport
of autophagosomes, indicating that they participate in this transport. Recent observations in
primary dorsal root ganglionic neurons support a maturation model in which autophago‐
somes initiate distally, engulfing mitochondria and ubiquitinated cargo, and move bidirec‐
tionally along microtubules driven by bound anterograde kinesin and retrograde dynein
motors [22]. Fusion with late endosomes or lysosomes may then allow autophagosomes to
escape from the early distal pool by robust retrograde dynein-driven motility. The involvement
of the dynein-dynactin complex in the movement of autophagosomes along microtubules to
lysosomes has also been demonstrated in non-neuronal cells [42]. Consistent with the forma‐
tion of an autolysosomal compartment, autophagosomes increasingly acidify as they approach
the cell soma, thereby fueling the catalysis of the degradation of their engulfed contents. Fully
acidified autolysosomes undergo bidirectional motility suggesting reactivation of kinesin
motors [22, 41].
The interaction of the autophagic membrane marker Atg8/LC3 with the microtubule-associ‐
ated protein 1B (MAP1B) [43] implicates microtubule-dependent, axon-specific regulation of
autophagosomes. Overexpression of MAP1B in non-neuronal cells reduces the number of LC3-
associated autophagosomes without impairing autophagic degradation. The scarcity of LC3-
labelled autophagosomes in CNS neurons under normal conditions may be explained by their
high expression levels of MAP1B [10, 36]. By modifying microtubule function, the LC3-MAP1B
interaction has been proposed to accelerate the delivery of LC3-autophagosomes to lysosomes,
thereby promoting efficient autophagic turnover [37]. The exact mechanism underlying the
involvement of microtubule in autophagosome formation, as well as targeting and fusion with
lysosomes is open to debate [44, 45]. Based on (i) the absence of obvious changes in LC3
autophagosomes when they are associated with phosphorylated MAP1B-P, (ii) the elevated
level of MAP1B-P bound to LC3 in dystrophic terminals containing a large number of
autophagosomes [36] and, (iii) the conserved role of MAP1B-P in axonal growth and repair
during development or injury (which implicates autophagy in remodelling axonal terminals
during regeneration) [46], the interactions of LC3 with MAP1B and MAP1B-P have been
proposed to represent a regulatory determinant of autophagy in axons under normal and
pathological conditions respectively [37].
2.3. Functions of neuronal autophagy
Neurons, as non-dividing cells, are more sensitive to toxic components than dividing cells.
Therefore, their survival and the maintenance of their specialized functions under physiolog‐
ical and pathological conditions is crucial requiring a tight quality control of cytoplasmic
components and their degradation. Autophagy is believed to be of particular importance in
the synaptic compartments of neurons where high energy requirements and protein turnover
are necessary to sustain synaptic growth and activity. The CNS displays relatively low levels
of autophagosomes under normal conditions, even after starvation, but requires an indispen‐
sable turnover of cytosolic contents by autophagy even in the absence of any disease-associated
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mutant proteins [10, 47, 48]. The scarcity of immature autophagosomes in neurons is likely to
reflect a highly efficient autophagic degradation in the healthy brain. Accordingly, inhibition
of autophagy causes neurodegeneration in mature neurons suggesting that autophagy may
regulate neuronal homeostasis [11, 12]. For example, abnormal protein accumulation and
eventual neurodegeneration are observed in the CNS of mice lacking the atg5 or the atg7 genes.
This implies that basal autophagy is normally highly active and required for neuronal survival
[11, 12]. The cardinal importance of autophagy in central neurons is further supported by
recent studies showing a rapid accumulation of autophagosomes in cortical neurons when
lysosomal degradation is inhibited. Thus, constitutive autophagy apparently plays an active
role in neurons even under nutrient-rich conditions [49, 50].
2.3.1. Axonal homeostasis
Constitutive autophagy is probably essential for axonal homeostasis. Suppression of basal
autophagy by either deleting an atg gene or inhibiting autophagic clearance in neurons
disrupts axonal transport of vesicles destined for lysosomal degradation, and causes axonal
swelling and dystrophy [11, 12, 37, 50]. For examples, Atg1/Unc-51 mutants in C. elegans show
defaults in axonal membranes [51], and Unc-51.1, the murine homologue of Unc-51 is necessary
for axonal extension, suggesting a possible role for these proteins in axonal membrane
homeostasis [20, 52, 53]. In the cerebellum, neuron-specific deletion of FIP200, a protein
implicated in autophagosome biogenesis, causes axon degeneration and neuronal death [13].
Altogether, these data suggest that autophagy is essential to maintain axonal structure and
function through retrograde axonal transport [16]. The degree of vulnerability and the
formation of intracellular inclusions vary significantly among the different types of CNS
neurons in mutant brains deficient in Atg5 or Atg7 suggesting disparate intrinsic requirements
for autophagy and relative levels of basal autophagy [20]. For example, while ubiquitinated
inclusions are rare in the Atg5- or Atg7-deficient PCs, these cells are among the most suscep‐
tible neurons to Atg 5/7 gene deletion [54, 55]. ULK1, the human homologue of Atg1 is
incorporated into the active NGF-TrkA complex after its K-63 polyubiquitination and associ‐
ation with p62 [52, 56]. The subsequent interaction of ULK1 with endocytosis regulators allows
trafficking of NGF-bound TrkA receptors into endocytic vesicles [57] providing a possible
mechanism of crosstalk between autophagy and endocytosis. By fusing with autophagosomes,
some membrane compartments, including endosomes, can be removed from axons and
degraded in lysosomes. This process maintains the homeostasis of the axonal membrane
networks and as such is essential for axonal physiology [20, 53].
Indeed, dysfunctional autophagy has been implicated in axonal dystrophy. Axonal swellings
occur in autophagy-deficient mouse brains [11, 12] and genetic ablation of Atg7 provokes cell-
autonomous axonal dystrophy and degeneration, inferring that autophagy is crucial for
membrane trafficking and turnover in axons [53]. In Atg5- or Atg7-deficient PCs, axonal
endings exhibit an accumulation of abnormal organelles and membranous profiles much
earlier than the somato-dendritic compartment [53, 54]. Axonal degeneration is increasingly
believed to precede somatic death by a non-apoptotic auto-destructive mechanism [58, 59].
The “dying-back” progressive retrograde degeneration of the distal axon is a likely model of
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the chronic injury observed in neurodegenerative diseases [59]. NGF-deprivation induces
autophagosome accumulation in the distal tips of neurites of PC12 cells, and knocking down
Atg7 or beclin 1 expression delays neurite degeneration of NGF-deprived sympathetic neurons
[60]. This suggests that overactive or deficient autophagy contributes to axonal degeneration
in a dying-back manner due to the fragility of the axonal tips [20].
2.3.2. Dendritic autophagy
Early autophagosomes have also been observed in dendrites and the cell body of neurons
suggesting that axon terminals are not be the only sites where neuronal autophagosomes form,
and that autophagy may play a regulatory function in dendrites under physiological and
pathological conditions [19]. Along this line, mTOR a key regulator of the autophagic pathway,
modulates postsynaptic long-term potentiation and depression, suggesting that autophagy
may critically control synaptic plasticity at the postsynaptic, dendritic compartment [61].
Further investigations are required to determine the specific roles of autophagy in dendrites
and axons.
Since autophagosomes can fuse with endosomes and form amphisomes, there is a link between
autophagy and endocytosis [62]. ESCRT proteins have recently been implicated in normal
autophagy [19, 63, 64]. The endocytic pathways, in particular multi-vesicular bodies (MVBs)
may serve as critical routes for autophagosomes to reach lysosomes, because defects in ESCRT
function prevents fusion or maturation of autophagosomes. The ESCRT-MVB pathway could
represent the primary, if not the only, route for delivering autophagosomes to lysosomes in
some cell types [20]. In neurons, a large part of the endocytosed cargo merges with the
autophagic pathway prior to being degraded by lysosomes [65]. Alterations in ESCRT function
have also been linked to autophagy-deficiency in fronto-temporal dementia (FTD) and
amyotrophic lateral sclerosis (ALS). In these cases, the particular vulnerability of the neurons
appears to be associated with a dysfunction in the autophagosome-MVB pathway in the
dendritic compartment [19].
2.3.3. Protein homeostasis
Neurons deficient in Atg5 or Atg7 exhibit an accumulation of polyubiquitinated proteins in
inclusion bodies even though the proteasome function is normal, suggesting that basal
autophagy prevents spontaneous protein aggregation and plays an essential role in protein
clearance and homeostasis in neurons. Such a function is even more critical in neurons
expressing disease-related proteins like the aggregate-prone mutant α-synuclein and poly‐
glutamine-containing proteins [66-68], although how autophagy selectively degrades these
disease-related proteins is unclear. The ubiquitin-associated protein p62 is a likely candidate,
providing a link between autophagy and selective protein degradation. Indeed, p62 binds
numerous proteins through multiple protein-protein interacting motifs, including one for LC3
[55, 56] and the ubiquitin-associated C-terminal domain which binds ubiquitinated proteins.
The relationship between p62 and autophagy is further supported by the observation that a
marked accumulation of p62 and LC3 occurs only when lysosomes, but not proteasomes, are
blocked. Furthermore, p62 protein levels are elevated in autophagy-deficient neurons [36, 55].
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This argues that p62 is a specific substrate of autophagic degradation rather than a molecule
involved in autophagosome formation since p62-knockout mice display intact autophago‐
somes and slower protein degradation. Autophagy-deficient cells and neurons accumulate
ubiquitin- and p62-positive inclusions, and this accumulation is greatly reduced by ablating
p62 [55, 69]. p62 with mutations in the LC3 recognition sequence escape autophagic degrada‐
tion, leading to the formation of inclusions, whereas those with mutations in the self-oligo‐
merizing domain PB1 are poorly degraded, but no protein inclusions form. Thus increased
levels and oligomerization of p62 are required for the formation of inclusion bodies, and their
degradation is facilitated by oligomerization. Ubiquitinated aggregates induced by protea‐
some inhibition are also reduced in p62-deficient cells suggesting that p62 is a general mediator
of inclusion formation and normally functions as an adaptator targeting proteins for auto‐
phagic degradation [20].
2.3.4. Neuronal autophagy in synapse development, function and remodeling
Neuronal autophagy has been recently shown to play an important role in synapse develop‐
ment. The ubiquitin-proteasome system negatively regulates growth of the neuromuscular
junction (NMJ) in Drosophila [70] whereas NMJ is positively regulated by neuronal autophagy;
a decrease or an increase in autophagy correspondingly affects synapse size [71]. Indeed, an
overexpression or a mutation of Atg1, a gene involved in autophagy induction, respectively
enhanced or decreased NMJ growth. Furthermore, this positive effect of autophagy on NMJ
development is mediated by downregulating Hiw, an E3 ubiquitin ligase which negatively
regulates synaptic growth by downregulating Wallenda (Wnd), a MAP kinase kinase [70- 72].
Although autophagy is considered as a nonselective bulk degradation process, it can regulate
specific developmental events in a substrate-selective mode [73, 74]. In C. elegans, when
presynaptic afferences are removed from postsynaptic cells, GABAA receptors are selectively
targeted to autophagosomes [73]. Accordingly, Hiw could traffic to autophagosomes via a still
unknown mechanism, although Hiw could be unselectively degraded by autophagy along
with other presynaptic proteins. Interestingly, the synaptic density in mice carrying an atg1
mutation is decreased due to excessive activity of the MAP kinase ERK, suggesting that
activated ERK negatively regulates synapse formation and that Atg1 regulates synaptic
structure by downregulating ERK activity [75]. As pointed out by Shen and Ganetzky [71],
autophagy is a perfect candidate to modulate synaptic growth and plasticity in function of
environmental conditions, resulting in plausible consequences in learning and memory.
Autophagy has recently been shown to regulate neurotransmission at the presynaptic level
[76]. Besides enhancing protein synthesis via the mTORC1 complex, mTOR activity inhibits
autophagy by an Atg13 phosphorylation-induced blockade of Atg1 [77]. In the nervous system,
mTORC1 promotes learning and synaptic plasticity dependent on protein synthesis [78- 80].
Conversely, the mTOR inhibitor rapamycin impedes protein synthesis and blocks cell injury-
induced axonal hyperexcitability and synaptic plasticity, as well as learning and memory [81,
82]. In prejunctional dopaminergic axons, inhibition of mTOR induces autophagy as shown
by an increase in autophagosome formation, and decreases axonal volume, synaptic vesicle
number and evoked dopamine release. Similarly, non-dopaminergic striatal terminals also
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display more autophagosomes and fewer synaptic vesicles. Conversely, chronic autophagy
deficiency in dopamine neurons increases dopaminergic axon size and evoked dopamine
release, and promotes rapid presynaptic recovery. Thus mTOR-dependent axonal autophagy
locally regulates presynaptic structure and function. In cultured brain slices, the occurrence of
autophagosomes in presynaptic terminals isolated from their cell bodies confirms that
autophagosomes are locally synthesized [83], and supports the view that this autophagy may
serve to modulate presynaptic terminal function by sequestrating presynaptic components
[76]. The global stimulating effect of chronic autophagy deficiency on dopaminergic neurons
is consistent with the implication of autophagy in neurite retraction of sympathetic neurons
in vitro [84] and neuritic growth in developing neurons [21].
There are only a few other reports indicating that autophagy may participate in synapse
remodeling. In the cerebellar cortex of the (Bax-/-;GluRδ2Lc) double mutant mouse (Fig. 2A),
prominent autophagic profiles are evident in parallel fiber terminals subjected to intense
remodeling in the absence of the PCs, their homologous target neurons [85]. As mentioned
above, endocytosed GABAA receptors are selectively targeted to autophagosomes in C.
elegans neurons [73], whereas autophagy promotes synapse outgrowth in Drosophila [71].
Autophagy may also modulate synaptic plasticity as recently demonstrated in mammalian
hippocampal neurons [61]. Here, neuronal stimulation by chemical LTD induces NMDAR-
dependent autophagy by inhibiting the PI3K-Akt-mTOR pathway. Enhanced autophagosome
formation in the dendrites and spines of these neurons targets internalized AMPA receptors
to lysosomes suggesting that autophagy contributes to the NMDAR-dependent synaptic
plasticity required to maintain LTD and assure certain brain functions [61]. A possible
mechanism for this formation of autophagosomes and autophagic degradation of AMPARs in
dendritic shafts and spines may involve a change in endosome cycling. The formation of more
amphisomes due to the fusion of endosomes with autophagosome [86, 87] would reduce the
recycling endosome population, and direct more AMPAR-containing endosomes to autopha‐
gosomes for lysosomal degradation. Another alternative, but not exclusive actor is p62. This
autophagosomal protein is important for LTP and spatial memory [88], interacts with AMPAR
and is required for the trafficking of AMPAR [89]. AMPAR via its interaction with p62 would
be trapped in autophagosomes as their number increased [61]. mTOR regulates protein
turnover in neurons by functioning at the intersection between protein synthesis and degra‐
dation. During learning and reactivation in the amygdale and hippocampus, rapamycin
inhibition of mTOR has recently been shown to impair object recognition memory [90],
implicating signaling mechanisms involved in protein synthesis, synaptic plasticity and cell
metabolism in this cognitive function.
2.4. Few autophagosomes, a feature of basal neuronal autophagy
Neurons are highly resistant to large-scale induction of autophagy in response to starvation,
probably due to the multiple energy sources available to assure their function [48]. Interest‐
ingly, the activity of mTOR, a negative regulator of autophagy is significantly reduced in
hypothalamic neurons from mice after a 48h starvation [91], although there are reports that
autophagy in neurons can be regulated independently of mTOR [92, 93]. For example, insulin
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impairs the induction of neuronal autophagy in vitro, but in its absence induction of autophagy
is mTOR-dependent. Furthermore, a potent Akt inhibitor provokes robust autophagy [92].
Thus insulin signaling maintains a low level of autophagosome biogenesis in healthy neurons
constituting a critical mechanism for controlling basal autophagy in neurons. In addition to
insulin signaling, multiple parallel signaling pathways including the mTOR pathway can
regulate autophagy in neurons. From these data, Yue and collaborators [20] have proposed
that basal autophagy in CNS neurons is regulated by at least two mechanisms: (1) a non-cell-
autonomous mechanism whereby regulators (nutrients, hormones and growth factors) are
supplied by extrinsic sources (glia, peripheral organs), (2) a cell-autonomous mechanism
controlled by intrinsic nutrient-mediated signaling or specific factors expressed in neurons.
Neurons may depend less on autophagy to provide free amino acids and energy under
physiological conditions given their quasi exclusive use of blood-born glucose as a source of
carbon and energy for protein synthesis. Accordingly, the primary function of neuronal
autophagy may be different than a primary response to starvation, and autophagy regulatory
mechanisms are likely to be specific in neurons. Furthermore, gender differences in autophagic
capacity have been suggested by the faster autophagic response to starvation of cultured
neurons from male rats compared to those from females [94]. While in vivo evidence of
neuronal autophagy mediated by nutrient signaling is still missing, a number of stress-related
signals, neuron injuries and neuropathogenic conditions trigger prominent formation and
accumulation of autophagosomes in neurons. During this process, neurons may undergo a
significant change in autophagy regulation, involving a deregulation that allows neurons to
switch from basal level (neuron-specific process featured by a low number of autophagosomes)
to an activated state (well-conserved induced autophagy with large-scale biosynthesis of
autophagosomes) [20]. Hypoxic-ischemia [95, 96], excitotoxicity [97-99], the dopaminergic
toxins, methamphetamine and MPP+ [65, 100, 101], proteasome inhibition [102-104], lysosomal
enzyme/lipid storage deficiencies [105-108] are examples of these pathological inducers of
neuronal autophagy (see below).
3. Autophagy in neuronal physiopathology
Autophagy normally protects effect against neurodegeneration, but defects in the autophagy
machinery are sufficient to induce neurodegeneration. Indeed, neuron-specific disruption of
autophagy results in neurodegeneration [11, 12]; for example PC-specific Atg7 deficiency
impedes axonal autophagy via an important p62-independent axonopathic mechanism
associated with neurodegeneration [55]. Furthermore, specific defects in selective autophagic
components or in the cargo selection process can induce neurodegeneration. This hypothesis
is supported by the studies of cargo recognition and degradation components, such as p62,
NBR1, or ALFY [109, 110]. Defects at any one of the autophagic steps can cause an abnormal
accumulation of cytosolic components and lead to disease states. Therefore, each step of the
autophagic process needs to be tightly regulated for efficient autophagic degradation.
The housekeeping role of neuronal autophagy is more evident when neurons are loaded with
pathogenic proteins [67]. In many neurodegenerative disorders, cytoplasmic, nuclear and
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extracellular inclusions composed of aggregated and ubiquitinated proteins are believed to
contribute to organelle damage, synaptic dysfunction and neuronal degeneration. The
autophagic process in diseased neurons participates in the clearance of abnormal aggregate-
prone proteins such as the expanded glutamine (polyQ)-containing proteins (e.g. mutant
huntingtin in Huntington’s disease (HD)), mutant forms of α-synuclein in familial Parkinson
disease (PD), different forms of tau in Alzheimer’s disease (AD), tauopathies and FTD, mutant
forms of SOD1 in motor diseases such as ALS, and mutant forms of PMP22 in peripheral
neuropathies are cleared from diseased neurons by autophagy [19, 20, 55, 56, 66, 67, 111-115].
However, accumulation of these intracellular aggregates is believed to play a significant role
in the etiology of neurodegenerative diseases including prion diseases (PrD) [3, 67]. One
common feature is the dramatic cyto-pathological accumulation of autophagosomes in injured
and degenerating neurons [116-121]. Such signs of defects in autophagy have been interpreted
as a result of an “autophagic stress”, or in other words an imbalance between protein synthesis
and degradation [116]. This has traditionally been viewed as a highly destructive cellular
mechanism, driving the cell to death [117]. In these diseases, it is now accepted that autophagy
eliminates aggregate-prone proteins and damaged organelles more efficiently than the
proteasome machinery. Since the proteasome is unable to degrade them [122], the clearance
of misfolded, aggregated proteins originating from neuropathologic deficits is highly depend‐
ent on autophagy. However, a blockade of the autophagic flux is likely to impede the clearance
of these proteins. The accumulation of aggregated proteins and organelles within the diseased
neurons then contributes to cell dysfunction and in the end results in cell death [16], (Fig. 3).
Indeed, pharmacological upregulation of autophagy reduces neuronal aggregates and slows
down the progression of neurological symptoms in animal models of tauopathy and HD [123],
AD [41, 124, 125] and PrD [126, 127].
The mechanisms that determine the activation of autophagy for the removal of aggregated
proteins are not clearly understood, but failure of the other proteolytic systems to handle the
altered proteins seems to at least partly underlie autophagy activation. Thus oligomers and
fibers of particular proteins can block the proteolytic activity of the ubiquitin-proteasome
system and chaperone-mediated autophagy (CMA) that results in autophagy upregulation
[128, 129]. In addition, sequestration of negative regulators of autophagy in the protein
aggregates could also provoke activation of this pathway. Thus it has been shown that blockage
of autophagy in neurons leads to the accumulation of aggregated proteins and neurodegen‐
eration even in the absence of aggregate-prone proteins [11, 12]. Although the specific reasons
for the failure of the proteolytic systems are unknown, factors such as enhanced oxidative
stress and aging seem to precipitate entry into a late failure stage when the activity of all
degradation systems are blocked or decreased, leading to accumulation of autophagic vacuoles
and aggregates and finally cell death [130].
Autophagy protects against cell death in the case of growth factor withdrawal, starvation and
neurodegeneration, but it is required for some types of autophagic cell death [131-134].
However, the role of autophagy as a positive mediator of cell death is not well understood in
mammalian systems, although many studies suggest that impaired autophagy sensitizes cells
and organisms to toxic insults. Atg1-dependent autophagy restricts cell growth [135]. Cells
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Figure 2. Autophagy in cerebellar neurons.A. Neuronal autophagy in the cerebellum of a Purkinje cell-deficient
Bax0/0;Grid2Lc/+ double mutant mouse. Autophagic-like profiles (arrowheads) in presynaptic parallel fiber boutons (PF)
in the cerebellar molecular layer. * intervaricose parallel fibers. B. Autophagolysosomes (arrowheads) characteristic of
neuronal autophagy in the soma of a cerebellar Purkinje cell (PC) of a prion protein-deficient Ngsk Prnp0/0 mouse. C-D.
Phagophores, autophagosomes (* in C) and autophagolysosomes (* in D) in the soma of cerebellar Purkinje cells (PC)
from prion protein-deficient Ngsk Prnp0/0 mouse maintained 7 days in vitro (DIV7) in organotypic culture. E. Autopha‐
gosome (*) forming from a Golgi dictyosome in the Purkinje cell soma (PC) of a transgenic mouse expressing a neuro‐
toxic Chi3 PrP-Dpl chimera. Go, normal Golgi dictyosome. Scale bars = 500 nm in A, C-E, 2 µm in B.
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deficient in Pdk1, a positive regulator of mTOR pathway [136], display autophagy and reduced
growth. The increased growth capacity that results from disrupting autophagy may contribute
to the tumorigenicity of cells mutant for tumor suppressors [38, 137, 138]. Overexpression of
Atg1 leads to apoptotic cell death [135]. Cells undergoing autophagic cell death display signs
of apoptosis [139], as do Atg1-null cells [135]. Thus, elevated levels of autophagy promote cell
death and the role of autophagy in cell death is likely to be context-dependent.
Neuronal autophagy is currently believed to constitute a protective mechanism that slows the
advance of neurodegenerative disorders, and that its inhibition is associated with neurode‐
generation [130]. Substantial attention is currently being focused on the molecular mechanisms
underlying the autophagic fight against neurodegeneration, the role of autophagy in early
stages of pathogenesis and therapeutical approaches to upregulate protective neuronal
autophagy. It is unclear whether accumulation of autophagic vacuoles in degenerating
neurons results from increased autophagic flux or impaired flux. A chronic imbalance between
autophagosome formation and degradation causes “autophagic stress” [140]. Due to obvious
therapeutic consequences, it is imperative to understand how autophagic stress occurs in each
autophagy-associated neurodegenerative condition: either a cellular incapacity to support an
excessive autophagic demand or a defective degradation (lysosomal) step [141].
4. Autophagy in prion diseases
4.1. Prion diseases
4.1.1. Infectious and familial prion diseases
Prion diseases (PrD) are transmissible spongiform encephalopathies (TSEs) which are fatal
neurodegenerative diseases in humans (Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträuss‐
ler-Scheinker syndrome (GSS), variant CJD (vCJD), fatal familial insomnia (FFI) and kuru) and
in animals (bovine spongiform encephalopathy (BSE), transmissible mink encephalopathy
(TME), chronic wasting disease (CWD) and scrapie). In humans, PrD manifest after a long
incubation period free of symptoms as a rapid progressive dementia that leads inevitably to
death. Severe loss of neurons with extensive astrogliosis and moderate microglial activation,
characteristic of all TSEs, results in a progressive spongiform degeneration of the brain tissue
which is reflected by ataxia, behavioral changes and, in humans, a progressive cognitive
decline [142-145]. According to the protein-only hypothesis [146], TSEs are caused by prions
that are believed to be proteinaceous infectious particles mainly consisting of PrPSC, an
abnormal isoform of the normal, host-encoded prion protein (PrPC), [142]. Prions are able to
catalyze a switch from PrPC conformation into an aggregated misfolded conformer PrPSC which
collects throughout the brain according to a prion strain-specific anatomo-pathologic signa‐
ture. These PrDs share a protein misfolding feature with other neurodegenerative diseases
(e.g. AD, PD and HD), [147].
The central role played by PrPC in the development of PrD was first illustrated by the obser‐
vation that disruption of the PrP gene (PRNP) in mice confers resistance to PrD and impairs
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the propagation of infectious prions [148], while PrP-overexpressing (tga20) mice exhibit
reduced incubation periods when compared with wild-type mice [149]. Overall, the current
data argue for a primary role of the neuronal, GPI-anchored PrPC in prion neuropathogenesis
[150].The subversion of PrPC function(s) as a result of its conversion into PrPSC is assumed to
account for prion-associated toxicity in neurons [151]. Whether PrPSC triggers a loss of PrPC
physiological function (loss-of-function hypothesis) or promotes a gain of toxic activity (gain-
of-function hypothesis), or both, is an ongoing debate in the TSE field [152]. Elucidating the
roles of PrPC in neurons should help to answer this question. Knockout experiments, however,
have failed to reveal any obvious physiological role for PrPC. Mice devoid of PrPC are viable
and display only minor phenotypic or behavioural alterations that vary according to the null
strain, and hence, these results do not permit one to assign a specific function to PrPC. Ex
vivo studies support the involvement of PrPC in copper homeostasis [153]. In addition, the
localisation of PrPC on the cell membrane and its affinity for the neuronal cell adhesion
molecule (N-CAM), laminin, and the laminin receptor [154, 155] have implicated PrPC in cell
adhesion. Such properties may reflect the involvement of PrPC in the outgrowth and mainte‐
nance of neurites, and even cell survival. Indeed, recent experimental evidence showing that
PrPC interacting with β1 integrin controls focal adhesion and turnover of actin microfilaments
in neurons substantiates a role for PrPC in neuritogenesis. Of note, integrins are well known
Figure 3. Impaired steps of neuronal autophagy in neurodegenerative disorders.A. Defective autophagosome
biogenesis. B. Blockage of retrograde transport and accumulation of autophagosomes in dystrophic neurites. C. Fail‐
ure of autophagosomes to fuse with lysosomes.
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inducers of autophagy (see review in chapter by Nollet and Miranti). Remarkably, during
neuronal differentiation, the downregulation of Rho kinase (ROCK) activity by PrPC is
necessary for neurite sprouting [156]. A stress-protective activity has also been assigned to
PrPC based on results obtained with primary neuronal cultures. Neuronal cells derived from
PrP-knockout mice are more sensitive to oxidative stress and serum deprivation than wild
type cells [157-159]. Moreover, after ischemic brain injury, PrPC-depleted mice revealed
enlarged infarct volumes [160-162]. This neuroprotective role of PrPC has been linked to cell
signaling events. The interaction of PrPC with the stress inducible protein (STI-1) generates
neuroprotective signals that rescue cells from apoptosis [163]. Previous studies of both
neuronal and non-neuronal cells substantiate the coupling of PrPC to signaling effectors
involved in cell survival, redox equilibrium and homeostasis (e.g. ERK1/2, NADPH oxidase
[164], cyclic AMP-responsive element binding protein (CREB) transcription factor and
metalloproteinases [165, 166]. According to these data, PrPC has been proposed to function as
a « dynamic cell surface platform for the assembly of signaling modules » [167]. Despite these
overall advances, the sequence of cellular and molecular events that leads to neuronal cell
demise in TSEs remains obscure [168, 169]. At present, one envisions that neuronal cell death
results from several parallel, interacting or sequential pathways involving protein processing
and proteasome dysfunction [170], oxidative stress [159, 171], apoptosis and autophagy [172].
4.1.2. Autophagy in prion-infected neurons
Prion propagation involves the endocytic pathway, specifically the endosomal and lysosomal
compartments that are implicated in trafficking and recycling, as well as the final degradation
of prions. Shifting the equilibrium between propagation and lysosomal clearance impairs the
cellular prion load. This and the presence of autophagic vacuoles in prion diseased neurons
[173, 174] suggest a role for autophagy in prion infection (reviewed in [172]). Indeed, the high
numbers of autophagic vacuoles observed in neurons from experimentally prion-infected mice
(Fig. 4A, B, Fig. 5) and hamsters is indicative of a robust activation of autophagy [175, 176].
Furthermore, autophagic vacuoles and multivesicular bodies have been detected in prion-
infected neuronal cells in vitro [177].The formation of autophagic vacuoles has recently been
observed in neuronal pericarya, neurites and synapses of neurons experimentally infected
with scrapie, CJD and GSS [174], as well as in neuronal synaptic compartments in humans
with certain PrD [173]. PrDs are further correlated with autophagy given that the Scrg1 protein
(encoded by the scrapie responsive gene1, Scrg1) is upregulated in scrapie and BSE-infected
brains, as well as in brains of patients with sporadic CJD [178-180] and is associated with
neuronal autophagosomes [181, 182]. This Scrg1 protein is thus, a new marker for autophagic
vacuoles in prion-infected neurons (Fig. 4A, B). In the brains of CJD and FFI patients and
experimentally scrapie-infected hamsters, increased cytoplasmic levels of LC3-II-immunos‐
tained autophagosomes have been demonstrated in neurons, again indicating autophagy
activation. In addition, the decreased p62 and polyubiquitinated proteins levels in hamster
and human brains infected with prion suggest an upregulation of autophagy with enhanced
autophagic flux and protein degradation. Downregulation of the mTOR pathway and
upregulation of the beclin 1 pathway in these infected tissues provide further evidence of
autophagy activation [183]. On the basis of these observations, Xu et al. [183] propose that
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neuronal autophagy is an intricate element of prion infections. They suggest that once PrPSC
enters host cells and is delivered to endosomes, it accumulates in amphisomes via fusion with
autophagosomes and then with lysosomes. At this initial stage of infection, PrPSC does not co-
localize with autophagosomes, probably because PrPSC levels are too low to be detected due
to their rapid degradation in autophagolysosomes. In agreement with this explanation,
blocking the fusion of autophagosomes with lysosomes using bafilomycin A1 permits the
visualization of PrP-PG14 and PrPSC in autophagosomes [183], as is the case for Aβ1-42 [184].
The role of lysosomes in PrDs is still controversial. Although autophagic lysosomal degrada‐
tion of PrPSC in infected neurons is supposed to clear prion aggregates and inhibit PrPSC
replication, there are indications that PrPSC may subvert the autophagic-lysosomal system to
promote the conversion of PrPC into PrPSC. Lysosomal inhibitors prevent the build-up of
PrPSC [126] and agonists of the autophagy-lysosome pathway enhance the clearance of PrPSC
[185, 186, 126]. However, as PrPSC production increases, the accumulating PrPSC may saturate
the clearance capacity of the system causing lysosomal disruption and release of PrPSC
aggregates into the neuroplasm. In turn this would cause cell stress and over-activate autoph‐
agy, as has been reported in prion-diseased brain tissue [183].
The octapeptide repeats region of PrPC has been shown to negatively influence autophagy. As
measured by LC3-II expression, autophagy induced by serum deprivation occurs earlier and
to a greater extent in hippocampal neurons from ZH-I PrnP-/- compared with those from wild
type mice. Reintroduction of PrPC, but not PrPC lacking its N-t octapeptide region, into ZH-I
PrnP-/-neurons delays this upregulation of autophagy [187]. The transconformation of PrPC
into PrPSC could interfere with the function of this domain and as a consequence, upregulate
autophagy. It is conceivable that the activation of autophagy observed in PrD models reflects
a defense mechanism designed to degrade prions and resist oxidative stress. A reduction in
autophagy combined with endosomal/lysosomal dysfunction has indeed been proposed to
contribute to the development of PrD [188]. Furthermore, the anti-cancer drug imatinib has
been shown to activate lysosomal degradation of PrPSC [186] and is a potent autophagy inducer
[189]. When administered early during peripheral infection, imatinib delays both PrPSC
neuroinvasion and the onset of clinical disease in prion-infected mice [190]. Upregulation of
autophagy has beneficial effects on the clearance of aggregate-prone proteins in PrD and other
neurodegenerative diseases [66, 111-115, 191, 192]. Both lithium and trehalose enhance PrPSC
clearance from prion-infected cells by inducing autophagy, as demonstrated by increases in
LC3-II protein and the number of GFP-LC3 puncta [193, 126]. Furthermore, PrPSC can be cleared
not only by mTOR-independent autophagy (lithium and trehalose), but also by the mTOR-
dependent route because the mTOR inhibitor rapamycin also causes a decrease in cellular
PrPSC. Lithium-induced autophagy also reduces PrPC levels. This treatment causes internali‐
zation of PrPC [194], and the consequent reduction of available membrane-bound PrPC is
known to decrease its conversion into pathologic PrPSC [195-198]. This would provide an
additional, indirect way to reduce PrPSC by reducing of PrPC with lithium treatment.
Whether autophagy-inducing compounds are candidates for therapeutic approaches against
prion infection has recently been investigated in prion-infected mice. Starting in the last third
of the incubation periods, treatment with rapamycin and to a lesser extent with lithium
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significantly prolonged incubation times compared to mock-treated control mice [126, 172].
Along this line, activation of the class III histone deacetylase Sirtuin 1 (Sirt1) has been shown
to mediate the neuroprotective effect of resveratrol against prion toxicity [199] and prevent
prion protein-derived peptide 106-126 (PrP106-126) neurotoxicity via autophagy processing
[200]. Moreover, Sirt1-induced autophagy protects against mitochondrial dysfunction induced
by PrP106-126, whereas siRNA knockdown of Sirt1 sensitizes cells to PrP106-126-induced cell
death and mitochondrial dysfunction. Finally, knockdown of Atg5 decreases LC3-II protein
levels and blocks the effect of a Sirt1 activator against PrP106-126-induced mitochondrial
dysfunction and neurotoxicity. Thus inducing Sirt1-mediated autophagy may be a principal
neuroprotective mechanism against prion-induced mitochondrial apoptosis. Nevertheless,
understanding the mechanisms underlying Sirt1-mediated autophagy against prion neuro‐
toxicity and mitochondrial damage merits further investigation, in particular determining the
Sirt1-mediated dowstream signaling network, including FOXOs, p53 and PGC-1α. More
recently, the mTOR inhibitor and autophagy inducer rapamycin has been shown to delay
disease onset and prevent PrP plaque deposition in a mouse model of the Gerstmann-
Sträussler-Scheinker PrD [127]. Here, the reduction in symtom severity and prolonged survival
correlate with increases in LC3-II levels in the brains of treated mice, suggesting that autophagy
induction enhances elimination of misfolded PrP before plaques form. This is in agreement
with the well known neuroprotective effects of rapamycin in various models of neurodege‐
nerative diseases with misfolded aggregate-prone proteins (e.g. PD [111], ALS [201], HD [115],
spinocerebellar ataxia [66, 202], FTD [203] and AD [41, 124, 125].
4.2. Doppel-expressing prion protein-deficient mice
Research efforts to determine the function of PrPC using knockout mutant mice have revealed
that large deletions in the PrPC genome result in the ectopic neuronal expression of the prion-
like protein Doppel (Dpl) causing late onset degeneration of PCs and ataxia in PrnP-/-mouse
lines, such as Ngsk [204], Rcm0 [205], ZH-II [206] and Rikn [207].
Similar PC degeneration is observed when the N-terminal truncated form of PrP is expressed
(ΔPrP) in Prnp-ablated mouse lines [208] and when Dpl is overexpressed [209, 210]. Of note,
full-length PrPC antagonizes the neurotoxic effects of both Dpl and ΔPrP [208-212], but not
PrPC lacking the N-terminal residues 23-88 [213]. These results imply that Dpl and ΔPrP induce
cell death by the same mechanism, likely by interfering with a cellular signaling pathway
essential for cell survival and normally controlled by full-length PrPC [209, 214]. The mecha‐
nism underlying Dpl-induced neurotoxicity is still under debate. PrP-deficient neurons
undergo Dpl-induced apoptosis in a dose-dependent, cell autonomous manner [215]. Oxida‐
tive stress is a likely candidate to play a role in the death of these neurons because NOS activity
is induced by Dpl both in vitro and in vivo [212, 216]. Endogenous, as well as exogenous
PrPC has been shown to inhibit Dpl-induced apoptosis, a neuroprotective function that has
been attributed to its BCL-2-like properties [158]. Like BCL-2, PrPC antagonizes mitochondrial
apoptotic pathways, thereby protecting neurons from cell death [217- 219]. In BAX-induced
apoptosis [220, 221], PrPC probably acts by preventing the conformational changes in BAX that
are necessary for its activation [222]. In primary cultures, Dpl-induced apoptosis of Prnp+/+ as
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Figure 4. Scrapie responsive gene 1 (Scrg1)-immuno-cytochemistry in prion-infected and prion protein-defi‐
cient neurons.A-B. Scrg1 immunogold labeling in central neurons of a clinically ill 22L-scrapie-infected mouse. Scrg1-
bound immunogold particles label autophagolysosomes (* in A) in a Purkinje cell dendrite (PCD) and an
autophagosome forming from a Golgi dictyosome (white asterisk in B) in the somatic neuroplasm of a pyramidal neu‐
ron (Py) of the CA3 field of the hippocampus. In this neuron, lysosomes (arrowheads) and immunogold particles label‐
ling Scrg1 surround a large autolysosome-like vacuole (black asterisk). C. Scrg1 immuno-fluorescent labeling of
Purkinje cells (arrowheads) in the cerebellar cortex of a prion protein-deficient Ngsk Prnp0/0 mouse. IGL, internal gran‐
ular layer; ML, molecular layer. Scale bars = 500 nm in A-B and 50 µm in C.
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well as PrnP-/- granule cells, has recently been shown to be inhibited by BAX deficiency or
pharmacologically blocking caspase-3 suggesting that it is mediated by Bax and caspase-3
[223]. These results further confirm in vivo data concerning the effects of Bax expression on PC
survival in the cerebellum of the Dpl-overexpressing Ngsk PrnP-/-mouse that we reported
several years ago [224]. In these mice, PC death is already significant as early as 6 months of
age. During aging, quantification of PC populations shows that significantly more PCs
survived in the Ngsk PrnP-/-:Bax-/- double mutant mice than in the Ngsk PrnP-/-mice. However,
the number of surviving PCs is still lower than wild type levels and less than the number of
surviving PCs in Bax-/- mutants. This suggests that neuronal expression of Dpl activates both
BAX-dependent and BAX-independent pathways of cell death. Interestingly, a partial rescue
of Ngsk PrnP-/-PCs is observed in Ngsk PrnP-/--Hu-bcl-2 double mutant mice, in a proportion
similar to that found in Ngsk PrnP-/-:Bax-/- mice, strongly supporting the involvement of BCL-2-
dependent apoptosis in Dpl neurotoxicity [225]. The capacity of BCL-2 to apparently compen‐
sate for the deficit in PrPC by partially rescuing PCs from Dpl-induced death suggests that the
BCL-2-like property of PrPC may counteract Dpl-like neurotoxic pathway in wild-type
neurons. Although not exactly identical to BCL-2, PrPC may functionally replace BCL-2 as it
decreases in the aging brain [222]. The N-terminal domain of PrPC which is partially homolo‐
gous to the BH2 domain of BCL-2 family of proteins [226, 227] is probably responsible for the
Figure 5. Neuronal autophagy in cerebellar neurons of a clinically ill 22L-scrapie-infected mouse. A. Accumula‐
tion of autophagosomes (arrowheads) in a main dendrite of a Purkinje cell (PCD) in the cerebellar molecular layer. *,
parallel fibers. B. Autophagosomes (arrowheads) in presynaptic axon terminals (black asterisks) establishing synapses
(arrows) on postsynaptic Purkinje cell dendritic spines (s). C. An intact parallel fiber bouton (black asterisk) makes a
synapse (arrow) on a Purkinje cell spine (s) in the upper part of the picture and another parallel fiber bouton (black
asterisk) containing an autophagosome (arrowhead) makes a synapse (arrow) on a putative interneuron dendrite (d)
in the bottom of the picture. Scale bars = 500 nm.
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neuroprotective functions of PrPC because BAX-induced apoptosis cannot be counteracted by
N-terminally truncated PrP. BCL-2 antagonizes the pro-apoptotic effect of BAX by interacting
directly with this BH2 domain [228-230], and this domain is missing in both Dpl and the
neurotoxic mutated forms of PrP: ΔPrP [208, 214, 231] and Tg(PG14)PrP [232]. Interestingly,
expression of Dpl fused to a BH2-containing octapeptide repeat and the N-terminal half of the
hydrophobic region of PrPC makes cells resistant to serum deprivation [233]. Furthermore, N-
terminal deleted forms of PrPC have been reported to activate both BAX-dependant and BAX-
independant apoptotic pathways [231].
4.2.1. Autophagy in prion protein-deficient mice
The Dpl-activated, BAX-independent cell death mechanism may involve neuronal autophagy
as we have detected the expression of Scrg1, a novel protein with a potential link to autophagy
in the Ngsk PrnP-/-PCs (Fig. 4C), [181]. Both neuronal Scrg1 mRNA and protein levels are
increased in prion-diseased brains [179, 180], and Scrg1 is associated with dictyosomes of the
Golgi apparatus and autophagic vacuoles in degenerating neurons of scrapie-infected Scrg1-
overexpressing transgenic and WT mice (Fig. 4A, B), [181, 182]. Both before and during PC
loss, protein levels of Scrg1 and the autophagic markers LC3-II and p62 are increased in Ngsk
PrnP-/-PCs, whereas their mRNA expression is stable, suggesting that the degradation of
autophagic products is impaired in these neurons [234, 235]. Autophagic profiles collect in
somato-dendritic and axonal compartments of Ngsk PrnP-/- (Figs. 2B, 6), but not wild-type PCs.
The most robust autophagy occurs in dystrophic profiles of the PC axons in the cerebellar
cortex (Fig. 6D) and at their preterminal and terminal levels in the deep cerebellar nuclei (Fig.
6A-C) suggesting that it initiates in these axons. Taken together, these data indicate that Dpl
triggers autophagy and apoptosis in Ngsk PrnP-/- PCs. As reflected by the abundance of
autophagosomes in the diseased Ngsk PCs, Dpl neurotoxicity induces a progressive dysfunc‐
tion of autophagy, as well as apoptosis. Whether this autophagy dysfunction triggers apoptotic
cascades or provokes autophagic cell death independent of apoptosis remains to be resolved.
In the Ngsk PrnP-/- PCs, the increased expression of LC3-II and p62 at the protein level, without
any change in mRNA levels, suggests that the ultimate steps of autophagic degradation are
impaired. This is further confirmed by the prominence of autophagolysosomes in these
neurons which indicate that the fusion of autophagosomes with lysosomes occurs normally,
but downstream, the autophagic flux is blocked.
To further investigate the neurodegenerative mechanisms induced by Dpl in Ngsk cerebellar
PCs, we are using an organotypic cerebellar culture system which allows an easier way to
approach mechanistic questions than in vivo models [236]. For this purpose, we have assessed
the growth and viability of PCs in cerebellar organotypic cultures from Ngsk and ZH-I PrnP-/-
mice using morphometric methods to measure PC survival and development [237]. The timing
and amplitude of PC growth impairment and neuronal death are similar in Ngsk and ZH-I
PrnP-/- cultures (Fig. 7). In addition, increased amounts of autophagic (LC3-II, Fig. 8) and
apoptotic (caspase-3, Fig. 9) markers are detected in protein extracts from both cultures
indicating that both apoptosis and autophagy (Fig. 2C, D) contribute to PC death in Ngsk [235]
and ZH-I cultures. This suggests that PrPC -deficiency, rather than Dpl expression, is respon‐
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sible for the neuronal growth deficit and loss in these cultures. For presently unknown reasons,
the neurotoxic properties of Dpl do not seem to contribute to the degeneration of Ngsk PCs in
these organotypic cultures. As the neurotoxicity induced by Dpl takes about 6 months to
develop in vivo, it is possible that organotypic cultures are not mature enough to model 6-
month-old cerebellar tissue. Nevertheless, ex vivo cerebellar organotypic cultures do provide
a suitable system for analyzing the mechanisms underlying the neurotoxic effects of PrPC-
deficiency and prion infections [238] using pharmacological and siRNA-based approaches.
Our results have shown that PrPC has a neuroprotective role in cerebellar PCs. As PCs survive
in vivo in the cerebellum of the ZH-I mouse, the death of the ZH-I PCs in the organotypic
Figure 6. Neuronal autophagy in the cerebellar deep nuclei of a prion protein-deficient Ngsk Prnp0/0 mouse.A.
A presynaptic terminal of a Purkinje cell axon (PCA) establishes symmetric synapses on a postsynaptic dendrite from a
neuron of the interpositus deep cerebellar nucleus (DCN) and contains an autophagosome (*). B. A double membrane
wrap sequesters autophagosomes (*) in a Purkinje cell axon varicosity (PCA) symmetrically synapsing (arrows) on den‐
drites from neurons of the dentate deep cerebellar nucleus (DCN). C. Mitophagy by double membranes wrapping
around mitochondria (m) in a Purkinje cell presynaptic axon terminal (PCA) making symmetric synapses (arrows) on
postsynaptic dendrites from dentate deep nuclear neurons (DCN). D. Dystrophic Purkinje cell axon (PCA) filled with
electron-dense autophagic profiles in the cerebellar internal granular layer. Scale bars = 500 nm in A-C, 2 µm in D.
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cultures is likely to stem from the inherent stress of the ex vivo conditions. As mentioned above,
PrPC negatively regulates autophagy as demonstrated by the upregulation of autophagy
following serum deprivation in PrnP-/- hippocampal neurons when compared to PrPC-
expressing neurons [187]. Recent results suggest that PrPC can directly modulate autophagic
cell death. Using antisens oligonucleotides targeting the Prnp transcript, the downregulation
of PrPC expression in glial and non-glial tumor cells induces autophagy-dependent, apoptosis-
independent cell death [239]. Previous data have shown that PrPC acts as a SOD [240] and
modulates the activity of Cu/Zn SOD by binding 5 Cu++ ions on its N-terminal octapeptide
repeat domain [153, 157, 241]. A recent study of the effects of H2O2-induced oxidative stress
on hippocampal neurons expressing PrPC or deficient in PrPC provides further support for the
protective role of PrPC against oxidative stress [242]. Although autophagy and apoptosis occur
in both lines, the Prnp-/- neurons are less resistant to H2O2-induced oxidative stress than the
Prnp+/+ neurons confirming the anti-oxidant activity of PrPC.
Furthermore, autophagy is more enhanced in Prnp-/- neurons than in Prnp+/+ neurons. In the
latter, this is due to H2O2-induced enhancement of autophagic flux, and in the former due to
H2O2-induced impairment of autophagic flux. Similarly, experiments using Atg7 siRNA to
inhibit autophagy have revealed that the increased autophagic flux in Prnp+/+ neurons protects
against H2O2 cytotoxicity. Thus a deficiency in Prnp may impair autophagic flux via H2O2-
Figure 7. Purkinje cell loss in cerebellar organotypic cultures from wild-type and Prnp-deficient mice. PCs
stained for calbindin by immuno-fluorescence were counted. This analysis reveals similar, significant reductions in the
number of PCs between DIV5 and DIV7 for Ngsk Prnp-/- (53.5%) and ZH-I Prnp-/- (59%) cultures. During this period, the
number of PCs in wild-type cultures is stable (p > 0.05). Although the number of PCs is not significantly different be‐
tween genotypes at DIV5, by DIV7 there are similar decreases in mutant organotypic cultures (Ngsk: 67.8% and ZH-I:
69%) compared to wild-type cultures (two-way ANOVA followed by post-hoc Tukey test; * p < 0.001).
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induced oxidative stress contributing to autophagic cell death [242]. Since autophagic flux is
apparently normal in both Prnp+/+ and Prnp-/- neurons in the absence of stress, the lack of
PrPC only seems to contribute to autophagy impairment under stress-induced conditions, such
as H2O2 treatment [242], stress-inducing in vitro conditions, as well as Dpl-induced toxicity.
 A 
B 
Figure 8. A. Western blot of the autophagic marker LC3B-II, in extracts prepared from organotypic cultures from wild-
type, Ngsk and ZH-I Prnp-/- mouse cerebellum at DIV3, 5 and 7. Actin was used as a loading control. B. Autophagy was
measured by quantifying the ratio of the band intensities of LC3B-II and LC3B-I (n ≥ 3 mice) which reflects the amount
of autophagosomes. Compared to wild-type cultures, this ratio increases in mutant cultures at DIV5 suggesting en‐
hanced autophagy and then decreases at DIV7 probably as a result of either autophagic degradation or PC death
(Kruskal-Wallis test followed by post-hoc Tukey test; * p < 0.05).
Figure 9. Western blot of the pro-apoptotic activated caspase-3. Activated caspase-3 is detected in extracts of or‐
ganotypic cultures from Ngsk and ZH-I Prnp-/- mouse cerebellum, but not from wild-type mouse cerebellum. Actin
serves as a loading control.
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4.2.2. Prion protein PrP-doppel Dpl chimeras
When overexpressed ectopically in neurons, mutations within the central region of PrPC are
associated with severe neurotoxic activity, similar to that of Dpl [231, 243]. The absence of these
segments, called central domains (CD) is believed to be responsible for neurodegeneration and
ataxia. To understand the dual neurotoxicity vs. neuroprotective roles of PrPC, transgenic mice
expressing a fusion protein made of the CD of PrPC inserted within the Dpl sequence have
been generated [244]. These mice failed to develop typical Dpl-mediated neurological disorder
indicating that this N-terminal portion of PrPC reduces Dpl toxicity. To further investigate Dpl-
like neurotoxicity, Lemaire-Vieille et al. recently generated lines of transgenic mice expressing
three different chimeric PrP-Dpl proteins [245]. Chi1 (Dpl 1-57 replaced with PrP 1-125) and
Chi2 (Dpl 1-66 replaced with PrP1-134) abrogates the pathogenecity of Dpl confirming the
neuroprotective role of the PrP 23-134 N-terminal domain against Dpl toxicity. However, when
Dpl 1-24 were replaced with PrP 1-124, these Chi3 transgenic mice that express a very low level
of the chimeric protein develop ataxia, as early as 5 weeks of age. This phenotype is only
rescued by overexpressing PrPC, and not by a single copy of full-length PrPC, indicating the
strong toxicity of the chimeric protein Chi3. The Chi3 mice exhibit severe cerebellar atrophy
with significant granule cell loss and prominent signs of autophagy in PCs (Fig. 2E). We
conclude that the first 33 amino acids of Dpl, that are absent in Chi1 and Chi2 constructs, confer
toxicity to the protein. This is confirmed in vitro by the highly neurotoxic effect of the 25-57
Dpl peptide on mouse embryo cortical neurons. Since this chimeric transgene is not expressed
by PCs in the transgenic mice expressing Chi3, the signs of autophagy displayed by these
neurons in vitro could result from the neurotoxic effect of the exogenous Chi3 chimeric protein,
as well as the deleterious effect of losing their primary afferences (i.e. the granule cells).
5. Perspectives
The beneficial effects that autophagy has on prion infections is currently supported by a
growing bulk of evidence from in vivo and ex vivo data and is strongly promising for future
mid-term therapeutic approaches. To further understand the fascinating interplay between
autophagy and PrDs, further investigations are necessary to decipher their molecular interac‐
tions. Important issues remain. How are the different phases of prion infection physiopathol‐
ogy i.e. propagation, trafficking, recycling and clearance connected with autophagy? Which
autophagic pathways are activated by prions - the mTOR-dependent, mTOR-independent or
both? The biological function of autophagy per se in prion infection is obscure as the cellular
levels of autophagy can apparently modify cell susceptibility to prion infection, although
changes in autophagy may be a pre-requisite or a consequence of a prion infection.
Overall, the results point to a need to counteract cell stress and to eliminate toxic aggregate-
prone proteins that eventually saturate the usual degradation pathways, including autophagy.
These are common features of prion disesase and most of the other neurodegenerative diseases
described in this review. Saturation of the autophagic machinery, loss or imbalance of
autophagic flux is believed to lead to neurodegeneration. Understanding how autophagy
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relates to these diseases is a first step for developing autophagy modulation-based therapies
for treating neurological disorders. This implies therapeutic consideration for each type of
autophagic default at a precise step of the neurodegenerative disease concerned.
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